Literature DB >> 24038962

Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.

Đenana U Miodragović1, Jeremy A Quentzel, Josh W Kurutz, Charlotte L Stern, Richard W Ahn, Irawati Kandela, Andrew Mazar, Thomas V O'Halloran.   

Abstract

Entities:  

Keywords:  X-ray diffraction; antitumor agents; arsenic; drug design; platinum

Mesh：

Substances：

Year:  2013        PMID： 24038962      PMCID： PMC3932145          DOI： 10.1002/anie.201303251

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  21 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

Review 2.  195Pt NMR--theory and application.

Authors:  Brett M Still; P G Anil Kumar; Janice R Aldrich-Wright; William S Price
Journal:  Chem Soc Rev       Date:  2006-11-17       Impact factor: 54.564

Review 3.  Arsenic trioxide - An old drug rediscovered.

Authors:  Ashkan Emadi; Steven D Gore
Journal:  Blood Rev       Date:  2010-05-15       Impact factor: 8.250

4.  Synthesis and structure of nickel-containing cuboidal clusters derived from [W3Se4(H2O)9]4+. Site-differentiated substitution at the nickel site in the series [W3NiQ4(H2O)10]4+ (Q = S, Se).

Authors:  Rita Hernandez-Molina; Maxim N Sokolov; Maria Clausen; William Clegg
Journal:  Inorg Chem       Date:  2006-12-25       Impact factor: 5.165

Review 5.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

Review 6.  Arsenic trioxide.

Authors:  Mark R Litzow
Journal:  Expert Opin Pharmacother       Date:  2008-07       Impact factor: 3.889

7.  Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment.

Authors:  Haimei Chen; Samuel Pazicni; Nancy L Krett; Richard W Ahn; James E Penner-Hahn; Steven T Rosen; Thomas V O'Halloran
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity.

Authors:  Steven van Zutphen; Elena Pantoja; Rosario Soriano; Carlos Soro; Duncan M Tooke; Anthony L Spek; Hans den Dulk; Jaap Brouwer; Jan Reedijk
Journal:  Dalton Trans       Date:  2005-12-07       Impact factor: 4.390

Review 9.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

10.  Arsenic-based antineoplastic drugs and their mechanisms of action.

Authors:  Stephen John Ralph
Journal:  Met Based Drugs       Date:  2008
View more
  14 in total

1.  Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.

Authors:  Ðenana Miodragović; Elden P Swindell; Zohra Sattar Waxali; Abraham Bogachkov; Thomas V O'Halloran
Journal:  Inorganica Chim Acta       Date:  2019-07-24       Impact factor: 3.118

2.  Iodide Analogs of Arsenoplatins-Potential Drug Candidates for Triple Negative Breast Cancers.

Authors:  Ðenana Miodragović; Wenan Qiang; Zohra Sattar Waxali; Željko Vitnik; Vesna Vitnik; Yi Yang; Annie Farrell; Matthew Martin; Justin Ren; Thomas V O'Halloran
Journal:  Molecules       Date:  2021-09-06       Impact factor: 4.927

Review 3.  Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.

Authors:  Elden P Swindell; Patrick L Hankins; Haimei Chen; Denana U Miodragović; Thomas V O'Halloran
Journal:  Inorg Chem       Date:  2013-10-22       Impact factor: 5.165

4.  Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.

Authors:  Đenana Miodragović; Antonello Merlino; Elden P Swindell; Abraham Bogachkov; Richard W Ahn; Sara Abuhadba; Giarita Ferraro; Tiziano Marzo; Andrew P Mazar; Luigi Messori; Thomas V O'Halloran
Journal:  J Am Chem Soc       Date:  2019-04-15       Impact factor: 16.383

5.  Multivalency in the inhibition of oxidative protein folding by arsenic(III) species.

Authors:  Aparna Sapra; Danny Ramadan; Colin Thorpe
Journal:  Biochemistry       Date:  2014-12-30       Impact factor: 3.162

6.  Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers.

Authors:  Anam Akhtar; Scarlet Xiaoyan Wang; Lucy Ghali; Celia Bell; Xuesong Wen
Journal:  J Biomed Res       Date:  2017-01-19

7.  Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.

Authors:  Giarita Ferraro; Alessandro Pratesi; Damiano Cirri; Paola Imbimbo; Daria Maria Monti; Luigi Messori; Antonello Merlino
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

Review 8.  Arsenic in medicine: past, present and future.

Authors:  Ngozi P Paul; Adriana E Galván; Kunie Yoshinaga-Sakurai; Barry P Rosen; Masafumi Yoshinaga
Journal:  Biometals       Date:  2022-02-21       Impact factor: 3.378

9.  Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity.

Authors:  Giarita Ferraro; Antonello Merlino
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 10.  Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.

Authors:  Damiano Cirri; Francesco Bartoli; Alessandro Pratesi; Emma Baglini; Elisabetta Barresi; Tiziano Marzo
Journal:  Biomedicines       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.